GlassScriptPhysician profile
David L Walt
NPI 1205895448
$2,150.65
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $149 · 2021: $656 · 2022: $210 · 2023: $73.48 · 2024: $16.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $339.58 | 2019-2022 | |
| Mylan Specialty L.P. | $273.37 | 2019-2022 | |
| Glaxosmithkline, LLC. | $251.86 | 2019-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $225.13 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $216.75 | 2019-2021 | |
| Pfizer INC. | $165.84 | 2019-2024 | |
| Amarin Pharma, INC. | $100.48 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $91.12 | 2019 | |
| Lilly USA, LLC | $72.98 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.82 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.39 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.73 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $41.54 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.60 | 2019-2021 | |
| Amgen INC. | $31.03 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $25.84 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $23.50 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.07 | 2021 | |
| Dexcom, INC. | $16.54 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.34 | 2019 | |
| Sanofi Pasteur INC. | $13.24 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.40 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.29 | 2020 | |
| Nestle Healthcare Nutrition INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Walt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.